Differentiating incretin-based therapies for population-based health care.

The American journal of managed care

Volumn 17, Issue 2 Suppl, 2011, Pages

  Calabrese, Dave ^a  

^a SXC company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; INCRETIN;

ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL PROTOCOL; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; WEIGHT REDUCTION;

BLOOD GLUCOSE; CARDIOVASCULAR SYSTEM; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; DRUG TOLERANCE; HUMANS; INCRETINS; RECEPTORS, GLUCAGON; WEIGHT LOSS;

EID: 80051710361     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)